Corpus Intelligence IC Memo — UNIVERSITY HEALTH SERVICES INC. 2026-04-26 04:01 UTC
IC Memo — UNIVERSITY HEALTH SERVICES INC.
Investment Committee Memorandum | GA | 482 beds | Grade C | EBITDA uplift $35.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UNIVERSITY HEALTH SERVICES INC.

CCN 110028 | RICHMOND, GA | 482 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

UNIVERSITY HEALTH SERVICES INC. is a 482-bed suburban community hospital in RICHMOND, GA with $487.4M in net patient revenue and a -8.5% operating margin. The hospital serves a payer mix of 32.6% Medicare, 8.3% Medicaid, and 59.1% commercial.

Thesis: Undervalued. Our ML models identify $35.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.5% to -1.2% (+736bps).

Net Revenue HCRIS$487.4M
Current EBITDA COMPUTED$-41.6M
Operating Margin COMPUTED-8.5%
Occupancy HCRIS67.2%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS31.1%
Distress Probability ML47.1%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
30
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of -8.5% places it below the state median. Among 30 size-comparable peers (241-964 beds), the median margin is -1.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (241-964), prioritizing same-state peers. 30 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UNIVERSITY HEALTH SERVICES IN (Target)GA482$487.4M-8.5%
NORTHSIDE HOSPITALGA719$2.58B-7.9%
NORTHEAST GEORGIA MEDICAL CENTGA645$1.55B4.4%
KENNESTONE HOSPITALGA642$1.50B15.3%
EMORY UNIVERSITY HOSPITALGA639$1.42B5.4%
EMORY UNIVERSITY HOSPITAL MIDTGA548$1.37B-15.4%
PIEDMONT HOSPITAL INC.GA569$1.32B4.0%
GRADY MEMORIAL HOSPITALGA694$1.19B-39.6%
NORTHSIDE HOSPITAL - GWINNETTGA404$1.07B-2.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $35.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$10.2M+210bp18mo
Cost to Collect4.5%2.5%$9.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$9.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.9M+122bp9mo
Clean Claim Rate88.0%96.0%$312K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$10.2M
Cost to Collect
$9.7M
Denial Rate Reduction
$9.6M
A/R Days Reduction
$5.9M
Clean Claim Rate
$312K
Total EBITDA Uplift$35.9M
Current EBITDA$-41.6M
+ RCM Uplift+$35.9M
Pro Forma EBITDA$-5.7M
Current Margin-8.5%
Pro Forma Margin-1.2%
WC Released (1x)$18.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-63.9M$84.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-63.9M$72.3M0.00x-100.0%
Bull Case9.0x11.0x$-57.5M$169.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-57.5M$168.4M0.00x-100.0%
Bear Case11.0x10.0x$-70.3M$-74.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-70.3M$-104.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 30 hospitals with 241-964 beds
  • Same-state prioritization (n=31)
  • Comp margins: P25=-12.2% / P50=-1.0% / P75=5.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.